Could Albumin Affect the Self-Assembling Properties of a Block Co-polymer System and Drug Release? An In-Vitro Study
This work investigated the influence of a model protein, bovine serum albumin (BSA), on the properties of a thermogelling formulation intended for administration inside body compartments where there is high albumin content, as in the case of inflamed joints; it also explored the relation between the variation of these properties and release performance of methotrexate (MTX), a drug used to treat forms of arthritis and rheumatic conditions.
The influence of BSA on the micellisation and gelation behaviour of Poloxamer 407, chosen as a model copolymer, was studied by differential scanning calorimetry (microDSC), dynamic light scattering (DLS), fluorescence spectroscopy and rheology studies. A release study of MTX loaded inside the hydrogel in presence and in absence of BSA was performed.
DLS and microDSC data revealed that the micellisation process was not affected by the protein, as demonstrated by unaltered micellar size and thermodynamic parameters. While the presence of BSA in the copolymer system reduced gel consistency, the hydrogel release performance was only slightly affected.
Our results suggested that the kinetics of MTX release mainly depended on the presence of the thermogelling copolymer, although other mechanisms related to BSA could be involved. Finally, the study assessed the feasibility of using a thermogelling hydrogel for in situ drug administration in areas with the presence of high protein concentrations.
KEY WORDSBSA methotrexate poloxamer 407 polymer-protein interaction sustained release
- 1.Mizushima Y, Miyake H, Fujiwara K, Ono N, Takikawa K. A highly topically active corticosteroid. Preliminary report. Arzneim Forsch/Drug Res. 1980;30(2):274–5.Google Scholar
- 2.Hoshi K. Clinical application of DDS, steroid therapy and NSAIDs. Nippon Rinsho Jpn J Clin Med. 1989;47(6):1302–7.Google Scholar
- 5.Horisawa E, Hirota T, Kawazoe S, Yamada J, Yamamoto H, Takeuchi H, et al. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res. 2002;19(4):403–10.CrossRefPubMedGoogle Scholar
- 6.Huang G, Zhang Z. Micro- and nano-carrier mediated intra-articular drug delivery systems for the treatment of osteoarthritis. J Nanotechnol. 2012.Google Scholar
- 12.Perinelli DR, Cespi M, Pucciarelli S, Casettari L, Palmieri GF, Bonacucina G. Effect of phosphate buffer on the micellisation process of Poloxamer 407: microcalorimetry, acoustic spectroscopy and dynamic light scattering (DLS) studies. Colloids Surf A Physicochem Eng Asp. 2013;436:123–9.CrossRefGoogle Scholar
- 18.BASF. Poloxamer 407-Thickening agent and gel former for the pharmaceutical industry. 2005.Google Scholar
- 19.Lakowicz JR. Quenching of fluorescence. Principles of fluorescence spectroscopy. 3th ed: Springer; 2007.Google Scholar
- 20.Lewis GA, Mathieu D, Phan-Tau-Luu R, editors. Pharmaceutical experimental design. Marcel Dekker, Inc.Google Scholar
- 21.Liebenberg W, Engelbrecht E, Wessels A, Devarakonda B, Yang W, De Villiers MM. A comparative study of the release of active ingredients from semisolid cosmeceuticals measured with Franz, enhancer or flow-through cell diffusion apparatus. J Food Drug Anal. 2004;12(1):19–28.Google Scholar
- 23.Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, et al. Topical and transdermal drug products. Pharmacopeial Forum. 2009;35(3):750–64.Google Scholar
- 35.Pucciarelli S, Bonacucina G, Bernabucci F, Cespi M, Mencarelli G, Fronzo G, et al. A study on the stability and enzymatic activity of yeast alcohol dehydrogenase in presence of the self-assembling block copolymer poloxamer 407. Appl Biochem Biotechnol. 2012;167(2):298–313.CrossRefPubMedGoogle Scholar